Correlation Engine 2.0
Clear Search sequence regions

Sizes of these terms reflect their relevance to your search.

Pyoderma gangrenosum is a diagnostic and therapeutic challenge. A misdiagnosis or delayed diagnosis can lead to increased morbidity and death. A fast workup and initiation of treatment is essential. In this review, we present new diagnostic criteria, which can ease the diagnosis, and we summarise the evidence of different treatment modalities. The evidence points towards local immunosuppressive treatment in mild disease, supplemented by systemic glucorticosteroids, ciclosporin or tumour necrosis factor-alpha inhibitors in severe cases. Other biologics are emerging.


Ewa Anna Burian, Tonny Karlsmark, Karsten Fogh, Rikke Bech. Pyoderma gangrenosum]. Ugeskrift for laeger. 2021 Jun 14;183(24)

Expand section icon Mesh Tags

Expand section icon Substances

PMID: 34120685

View Full Text